JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Healthcare | 10.91% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
CVR Partners
UAN
$1.31B
| $3.15M | ﹤0.01% |
306,068
+9,822
| +3% | +$213K |
|
2502
Ormat Technologies
ORA
$7.06B
| $3.15M | ﹤0.01% |
46,521
-15,456
| -25% | -$1.17M |
|
2503
Installed Building Products
IBP
$6.39B
| $3.15M | ﹤0.01% |
78,914
+30,193
| +62% | +$1.95M |
|
|
EGRX
2504
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.15M | ﹤0.01% |
68,394
-7,875
| -10% | -$395K |
|
2505
Quanta Services
PWR
$103B
| $3.14M | ﹤0.01% |
99,031
+1,888
| +2% | +$70.2K |
|
2506
Glaukos
GKOS
$10.9B
| $3.14M | ﹤0.01% |
101,686
+9,823
| +11% | +$504K |
|
2507
Galicia Financial Group
GGAL
$6.97B
| $3.14M | ﹤0.01% |
445,028
+317,888
| +250% | +$4.04M |
|
2508
Horace Mann Educators
HMN
$2.13B
| $3.13M | ﹤0.01% |
85,678
-18,976
| -18% | -$783K |
|
|
INN
2509
Summit Hotel Properties
INN
$651M
| $3.13M | ﹤0.01% |
741,368
+118,540
| +19% | +$1.12M |
|
2510
Insmed
INSM
$27B
| $3.13M | ﹤0.01% |
195,211
-149,586
| -43% | -$3.55M |
|
2511
MeiraGTx Holdings
MGTX
$1.25B
| $3.12M | ﹤0.01% |
231,793
+43,544
| +23% | +$735K |
|
2512
Triumph Financial Inc
TFIN
$1.87B
| $3.11M | ﹤0.01% |
119,787
+74,545
| +165% | +$2.58M |
|
|
CTT
2513
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $3.11M | ﹤0.01% |
430,852
+242,277
| +128% | +$2.32M |
|
|
SGI
2514
Somnigroup International
SGI
$13.9B
| $3.11M | ﹤0.01% |
284,664
+36,580
| +15% | +$695K |
|
|
WW
2515
DELISTED
WW International
WW
| $3.11M | ﹤0.01% |
183,732
-26,986
| -13% | -$839K |
|
|
PRO
2516
DELISTED
PROS Holdings
PRO
| $3.11M | ﹤0.01% |
100,089
+73,465
| +276% | +$3.67M |
|
|
HTZ
2517
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $3.11M | ﹤0.01% |
502,535
+469,756
| +1,433% | +$6.35M |
|
2518
PUT
Cigna
CI
$74.7B
| $3.1M | ﹤0.01% |
17,500
+13,276
| +314% | +$2.58M |
|
|
PDCE
2519
DELISTED
PDC Energy, Inc.
PDCE
| $3.1M | ﹤0.01% |
498,893
-51,515
| -9% | -$928K |
|
|
VRTV
2520
DELISTED
VERITIV CORPORATION
VRTV
| $3.09M | ﹤0.01% |
393,145
+1,317
| +0.3% | +$16.7K |
|
2521
Alamo Group
ALG
$2.01B
| $3.09M | ﹤0.01% |
34,755
+12,130
| +54% | +$1.4M |
|
2522
Denali Therapeutics
DNLI
$3.9B
| $3.08M | ﹤0.01% |
175,843
+98,101
| +126% | +$2.05M |
|
2523
Federal Signal
FSS
$7.68B
| $3.08M | ﹤0.01% |
112,827
+69,337
| +159% | +$2.16M |
|
2524
CALL
Karyopharm Therapeutics
KPTI
$45.8M
| $3.07M | ﹤0.01% |
+10,667
| New | +$2.94M |
|
2525
CALL
Bristol-Myers Squibb
BMY
$130B
| $3.07M | ﹤0.01% |
55,100
-65,000
| -54% | -$3.97M |
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2020 filing shows 363 new, 2,382 increased, 2,149 reduced and 692 closed positions. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M. The largest sale was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 363 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.